Genetic evolution of breast cancers III: Age-dependent variations in the correlations between biological indicators of prognosis

Breast Cancer Research and Treatment

Volumn 34, Issue 1, 1995, Pages 25-33

  Remvikos, Yorghos ^a   Magdelenat, Henri ^a   Dutrillaux, Bernard ^a  

^a INSTITUT CURIE   (France)

Author keywords

age at diagnosis; breast cancer; DNA flow cytometry; genetic evolution; prognostic factors

Indexed keywords

BROXURIDINE; DNA; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CELL PROLIFERATION; CONTROLLED STUDY; DIPLOIDY; DNA DETERMINATION; EVOLUTION; FEMALE; FLOW CYTOMETRY; GENETIC ANALYSIS; HISTOGRAM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; TRIPLOIDY;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMAN; MIDDLE AGE; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; STATISTICS;

EID: 0028938928     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF00666488     Document Type: Article

References (36)

1. Exogenous estrogens and other factors in the epidemiology of breast cancer
2. The role of estrogens and progestagens in the epidemiology and prevention of breast cancer
3. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark
4. Cancer patient survival: surveillance, epidemiology, and end results program, 1973–1979
5. Breast cancer a curable disease? A study of 14731 women with breast cancer from the Cancer Registry of Norway
6. Age as a prognostic factor in premenopausal breast carcinoma
7. Breast cancer genetic evolution I: Data from cytogenetics and DNA content
8. Genetic evolution of breast cancer II: Relationship with estrogen and progesterone receptor expression
9. Proliferative activity of breast cancers increase in the course of genetic evolution as defined by cytogenetic analysis
10. Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma
11. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer
12. Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer
13. Relative worth of estrogen and progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from the NSABP protocol B-06
14. Cell kinetics as a prognostic indicator in node-negative breast cancer
15. Growth rate, kinetics of tumor cell proliferation, and long-term outcome in human breast cancer
16. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer
17. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry
18. Indicators of prognosis in node-negative breast cancer
19. DNA index, S-phase fraction, histological grade and prognosis in breast cancer
20. DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study
21. Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas - a 10 year survival study
22. Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation
23. Histological grading and prognosis in breast cancer
24. Consensus review of the clinical utility of DNA flow cytometry in carcinoma of the breast
25. Correlation of cell-cycle kinetics, hormone receptors, histopathology and nodal status in human breast cancer
26. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer
27. Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer
28. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens
29. The relation of flow cytometry to clinical and biologic characteristics in women with node-negative primary breast cancer
30. Genetic analysis of breast cancer in the cancer and steroid hormone study
31. Breast cancer genes: how many, where and who are they?
32. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients
33. Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome
34. Effect of DNA ploidy classification on prognosis in breast cancer
35. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction